Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 42 Uterine Cervical Neoplasms 41 Breast Neoplasms 10 Vaginal Neoplasms 6 Neoplasms 6 Endometrial Neoplasms 6 Liver Neoplasms 5 Uterine Neoplasms 4 Sarcoma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Vulvar Neoplasms 3 Retinoblastoma 3 Radiation Injuries 3 Ovarian Neoplasms 3 Hyperthermia 3 Carcinoma, Hepatocellular 3 Adenocarcinoma 3 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Melanoma 2 Head and Neck Neoplasms 2 Gynecologic Cancer 2 Desmoplastic Small Round Cell Tumor 2 Deglutition Disorders 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Breast Carcinoma In Situ 2 Uveal Melanoma 1

Interventions

Ipilimumab 17 Nivolumab 15 incomplete Freund's adjuvant 8 Cyclophosphamide 7 CTLA-4 Antigen 7 pembrolizumab 6 Ranibizumab 6 sargramostim 5 Radiosurgery 5 Blood Specimen Collection 5 tebentafusp 4 Temozolomide 4 Surveys and Questionnaires 4 Magnetic Resonance Spectroscopy 4 MART-1 Antigen 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Biopsy 4 Bevacizumab 4 fludarabine phosphate 3 fludarabine 3 aflibercept 3 Thalidomide 3 Sunitinib 3 Specimen Handling 3 MAGEA3 protein, human 3 Interleukin-2 3 130-nm albumin-bound paclitaxel 3 relatlimab 2 olaparib 2 montanide ISA 51 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Uveal Melanoma × Brachytherapy × Clear all

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡